Arcam, listed on NASDAQ Stockholm, has received an order for an Arcam Q10 system from a leading research institute in South America. The system will be used for the research on medical implants.
”This is the first order from a customer in South America, thus expanding our geographic markets”, says Magnus René, CEO of Arcam.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail: magnus [dot] rene [at] arcam [dot] com